◀ top stories
 

The CRISPR patent decision: Your six takeaways

Original story at STAT• 3 mentions • 5 days ago

STAT 5 days ago

 
W ith the Broad Institute’s big win on Wednesday in its battle over key patents on the CRISPR-Cas9 genome editing technology, everything is now crystal clear. Kidding! The University of California seemed to be the loser, since the patent judges denied its effort to effectively block the Broad’s patents. But in a call with reporters, Paul Alivisatos, UC Berkeley’s vice chancellor for research, was upbeat that the ruling would allow UC’s patent claims to finally “move forward.” Berkeley biochemist Jennifer Doudna, whose pioneering CRISPR discoveries UC has been trying to patent, pronounced herself “delighted.” Alivisatos dodged a question about why,
 
 
◀ top stories
 

What they're saying:

17 Feb
no influencer data matched to the comment @
RT @sxbegle: On the #CRISPR patent decision, your 6 takeaways, incl'g green tennis balls: https://t.co/mvFe3PGp55
16 Feb
no influencer data matched to the comment @
RT @sxbegle: On the #CRISPR patent decision, your 6 takeaways, incl'g green tennis balls: https://t.co/mvFe3PGp55
16 Feb
no influencer data matched to the comment @
RT @dylanlscott: Trying to figure out what the big ruling on CRISPR patents means? Read @sxbegle: https://t.co/TUqZNgp5lG